These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23342614)

  • 1. [Correction of urodynamic disorders in women with obstructive urination].
    Neĭmark AI; Razdorskaia MV; Kondrat'eva IuS; Muzalevskaia NI
    Urologiia; 2012; (5):34-7. PubMed ID: 23342614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension.
    Drake MJ; Chapple C; Sokol R; Oelke M; Traudtner K; Klaver M; Drogendijk T; Van Kerrebroeck P;
    Eur Urol; 2015 Feb; 67(2):262-70. PubMed ID: 25070148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN).
    Van Kerrebroeck P; Haab F; Angulo JC; Vik V; Katona F; Garcia-Hernandez A; Klaver M; Traudtner K; Oelke M
    Eur Urol; 2013 Sep; 64(3):398-407. PubMed ID: 23537687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tamsulosin in the treatment of detrusor-sphincter dyssynergia of the urinary bladder in patients with multiple sclerosis].
    Stankovich EIu; Borisov VV; Demina TL
    Urologiia; 2004; (4):48-51. PubMed ID: 15457955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative urodynamic evaluation may predict voiding dysfunction in women undergoing pubovaginal sling.
    Miller EA; Amundsen CL; Toh KL; Flynn BJ; Webster GD
    J Urol; 2003 Jun; 169(6):2234-7. PubMed ID: 12771757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study.
    Athanasopoulos A; Gyftopoulos K; Giannitsas K; Fisfis J; Perimenis P; Barbalias G
    J Urol; 2003 Jun; 169(6):2253-6. PubMed ID: 12771763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined treatment of patients with erectile dysfunction and urination disorders].
    Kamalov AA; Osmolovskiĭ BE; Okhobotov DA; Khodyreva LA; Takhiradze TB; Takhiradze AM; Gevorkian AR
    Urologiia; 2013; (3):29-30, 32-3. PubMed ID: 23987045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and urodynamic evaluation of efficacy of conservative treatment of urination disorders in patients with benign prostate hyperplasia].
    Danilov VV; Danilova TI; Danilov VV; Danilov VV
    Urologiia; 2013; (5):55-8. PubMed ID: 24437242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of α1 antagonist and cholinesterase inhibitor on cystometric parameters in lumbar canal stenosis rats with underactive bladder.
    Sekido N; Kida J; Wakamatsu D; Okada H; Matsuya H
    Urology; 2014 Nov; 84(5):1248.e9-15. PubMed ID: 25443946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Obstructive bladder neck syndrome in women].
    Pavlica P; Viglietta G; Ramini R; Barozzi L; Cuzzocrea D; Romagnoli P
    Radiol Med; 1989 May; 77(5):496-500. PubMed ID: 2748961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voiding dysfunction in older women with overactive bladder symptoms: A comparison of urodynamic parameters between women with normal and elevated post-void residual urine.
    Park J; Lavelle JP; Palmer MH
    Neurourol Urodyn; 2016 Jan; 35(1):95-9. PubMed ID: 25400112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of bethanechol and cisapride on urodynamic parameters in patients undergoing radical hysterectomy for cervical cancer. A randomized, double-blind, placebo-controlled study.
    Madeiro AP; Rufino AC; Sartori MG; Baracat EC; Lima GR; Girão MJ
    Int Urogynecol J Pelvic Floor Dysfunct; 2006 May; 17(3):248-52. PubMed ID: 15959612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transurethral incision of congenital obstructive lesions in the posterior urethra in boys and its effect on urinary incontinence and urodynamic study.
    Nakamura S; Kawai S; Kubo T; Kihara T; Mori K; Nakai H
    BJU Int; 2011 Apr; 107(8):1304-11. PubMed ID: 20804485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Bladder Neck and Urethral Sphincter Dysfunction in Men with Persistent Bothersome Lower Urinary Tract Symptoms after α-1 Blocker Treatment.
    Ke QS; Jiang YH; Kuo HC
    Low Urin Tract Symptoms; 2015 Sep; 7(3):143-8. PubMed ID: 26663729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α1-blocker tamsulosin as initial treatment for patients with benign prostatic hyperplasia: 5-year outcome analysis of a prospective multicenter study.
    Masumori N; Tsukamoto T; Horita H; Sunaoshi K; Tanaka Y; Takeyama K; Sato E; Miyao N
    Int J Urol; 2013 Apr; 20(4):421-8. PubMed ID: 22989348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe].
    Chapple ChR; Montorsi F; Tammela TL; Wirth M; Koldewijn E; Fernandez Fernandez E
    Urologiia; 2012; (5):38-42, 44-5. PubMed ID: 23342615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term outcomes of the use of α-blockers tamsulosin in men with lower urinary tract symptoms and benign prostatic hyperplasia].
    Krivoborodov GG; Tur EI
    Urologiia; 2014; (6):47-8, 50. PubMed ID: 25799727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detrusor contraction duration as a urodynamic parameter of bladder outlet obstruction for evaluating men with lower urinary tract symptoms.
    Ameda K; Steele GS; Sullivan MP; Stember D; Yalla SV
    J Urol; 1998 Aug; 160(2):482-6. PubMed ID: 9679903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modern approaches to the treatment of patients with overactive bladder and urge urinary incontinence].
    Razdorskaia MV; Neĭmark AI; Aliev RT
    Urologiia; 2013; (1):44-6, 48-9. PubMed ID: 23662495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of urethral resistance after the administration of an alpha-adrenoceptor blocking agent, urapidil, for neuropathic voiding dysfunction.
    Yamanishi T; Yasuda K; Tojo M; Hattori T; Sakakibara R; Shimazaki J
    Paraplegia; 1994 Apr; 32(4):271-6. PubMed ID: 7912822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.